Morgan Stanley raised the price target for the Bausch + Lomb Corp (NYSE:BLCO) stock from “an Equal-weight” to “an Overweight”. The rating was released on May 06, 2024, according to finviz. We ...

In today's trading, Bausch Lomb Corporation shares opened at $20.83 and closed at $19.92. prices ranged from a low of $19.92 to a high of $20.83. Shares dipped -4.05% from the previous day's close of ...

Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.

Bausch + Lomb has received seven reports of growths in the product’s containers, though there have been no reports of illness ...

Morgan Stanley upgraded Bausch + Lomb (BLCO) to overweight, citing improving margins, and raised its price target to $18.

Fintel reports that on May 6, 2024, Morgan Stanley upgraded their outlook for Bausch + Lomb (NYSE:BLCO) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 35.98% Upside As of May 2, 2024 ...

D og owners have been advised to request a refund for their purchases of Project Watson Eyelid Wipes after the pharmaceutical ...

XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea ...

LAVAL, QC / ACCESSWIRE / May 15, 2024 / Bausch Health Companies Inc. (NYSE:BHC) (TSX:BHC) today announced the results of its 2024 annual meeting of shareholders.

(NEXSTAR) — Pharmaceutical company Bausch + Lomb is recalling about 32,000 units of its Project Watson Eyelid Wipes for dogs over concerns that the products may unintentionally grow bacteria and ...

(NEXSTAR) — Pharmaceutical company Bausch + Lomb is recalling about 32,000 units of its Project Watson Eyelid Wipes for dogs over concerns that the products may unintentionally grow bacteria and ...

Morgan Stanley has upgraded Bausch + Lomb (NYSE:BLCO) to overweight, citing improving margins. In a note released early Monday, the investment bank said the company’s underlying EBITDA margin is ...